Mäklin, Kiira
Lampela, Pasi
Lin, Julian
Sirpa, Hartikainen
Tolppanen, Anna-Maija
Funding for this research was provided by:
Business Finland (733/31/2020, 733/31/2020, 733/31/2020)
Article History
Received: 6 October 2022
Accepted: 27 March 2023
First Online: 4 April 2023
Declarations
:
: Register maintainers have approved the MEDALZ study plan. Data were pseudonymized before submission to the research team and study participants were not contacted. Therefore, according to Finnish legislation (including Personal Data Act 23/1999, Act on the Openness of Government Activities 621/1999 and Act on the Secondary Use of Health and Social Data 552/2019 (and previous Act on the National Healthcare registers, not official English translation as this is not available 556/1989) the study has been granted an exemption from requiring ethics approval or informed consent. We confirm that all methods were carried out in accordance with relevant guidelines and regulations including the Declaration of Helsinki.
: Not applicable.
: SH has received lecture fee from Eisai. AMT acknowledges a research grant from Amgen, paid to the institution where she is employed (outside of the submitted work). KM, PL, JL have nothing to declare.